News

Christian Lienhardt Discusses the Newly Launched TB-PACTS Database

Christian Lienhardt, from WHO, discusses the launch of TB-PACTS, the new data-sharing platform for TB clinical trials. This marks the beginning of an exciting new tool in the fight against TB. Announced on April 18th, TB-PACTS combines clinical trial data from Critical Path Institute (C-Path), the Special Programme for Research and Training in Tropical Diseases (TDR), TB Alliance, and St. George’s, University of London. Hosted on the C-PATH website, it strives to standardize all Phase III tuberculosis clinical trial data. According to the website, “researchers can access and analyze data in aggregate, or filter and view individual patient-level data from the REMoxTB, RIFAQUIN and OFLUTUB clinical trials”.

TB-PACTS, which stands for TB-Platform for Aggregation of Clinical TB Studies, is accessible to researchers after registering an online application. The website informs users it may take up to 4 weeks for the application to be processed. Once registered users are able and encouraged to contribute data as well. The site assures users that they retain ownership of their data and that the platform is secure.

As Dr. Lienhardt discusses, having a larger database improves and refines the ability to analyze the data. It provides an increased sample size, an opportunity to perform analysis of specific populations, and an increased likelihood of finding commonalities that were not picked up in the single trials.

Related Links

TB-PACTS Website

Christian Lienhardt Discusses TB-PACTS

TB-PACTS Press Release

More News
29 Nov 2018
On December 6, 2018, at 7AM EST, TREAT TB will host a capacity building webinar on community engagement in MDR-TB clinical trials. It will feature a presentation from Ezio Tavora dos Santos Filho, STREAM Community Engagement Coordinator from REDE-TB , followed by a question and answer session. The...
2 Oct 2018
The first ever U.N. General Assembly’s high-level meeting (UNHLM) on tuberculosis took place on Wednesday, September 26 in New York City. The U.N. delegation of countries agreed to ambitious targets including a commitment to finding 40 million undiagnosed cases of TB by the end of 2022 and...
18 Sep 2018
In an article written by Lucica Ditiu, Executive Director, Stop TB Partnership, and Jacqueline Huh, Head, Strategic Initiatives & Innovative Financing, Stop TB, the 'valleys of death' that hold back TB new tools innovation are discussed. These two valleys occur between new tool development and...